Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis
Open Access
- 18 September 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (60) , 101203-101214
Abstract
Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasisKeywords
This publication has 35 references indexed in Scilit:
- Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4Cancer Science, 2013
- GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patientsJournal of Neuro-Oncology, 2013
- Increased Expression of Phosphatidylcholine (16:0/18:1) and (16:0/18:2) in Thyroid Papillary CancerPLOS ONE, 2012
- Metabolomics of Human Cerebrospinal Fluid Identifies Signatures of Malignant GliomaMolecular & Cellular Proteomics, 2012
- Balance of human choline kinase isoforms is critical for cell cycle regulationThe FEBS Journal, 2012
- Evaluating the utility of N1,N12-diacetylspermine and N1,N8-diacetylspermidine in urine as tumor markers for breast and colorectal cancersClinica Chimica Acta, 2010
- MALDI-TOF Mass Spectrometry Analysis of Cerebrospinal Fluid Tryptic Peptide Profiles to Diagnose Leptomeningeal Metastases in Patients with Breast CancerMolecular & Cellular Proteomics, 2005
- CSF proteome: a protein repository for potential biomarker identificationExpert Review of Proteomics, 2005
- Germ cell tumors of the CNS in children: recent advances in therapyChild's Nervous System, 1999
- Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasisAnnals of Neurology, 1995